Labixiaoxin (01262) Releases Monthly Return Showing Unchanged Share Capital in November 2025
Bulletin Express
Dec 01
Labixiaoxin Snacks Group Limited (Stock Code: 01262) disclosed its Monthly Return for Equity Issuer, confirming that the authorized share capital remained at 500,000,000 ordinary shares with a par value of USD 0.001 each, totaling USD 500,000. No increase or decrease was reported during November 2025.
The number of issued shares remained at 218,416,088, with no treasury shares. Under the share option scheme adopted on 23 June 2021, no new shares were issued in November, and 13,289,770 shares may still be issued upon exercise of outstanding share options. No warrants, convertibles, or other share issuances were reported for the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.